Results 131 to 140 of about 10,484,401 (313)

Deconstruction fashion design through an analysis of Korean fashion design

open access: yesThe Research Journal of the Costume Culture, 2022
Minjae Han, Younhee Lee
openaire   +1 more source

2009 FIT Fashion Show: Knitwear, Sportswear, Menswear, pt.2

open access: yes
Knitwear, sportswear, and menswear designed by graduating students in FIT's BFA fashion design program.

core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

2010 FIT Fashion Show part 2: Intimate Apparel

open access: yes
Intimate Apparel designed by graduating students in FIT's BFA fashion design program.

core  

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

2010 FIT Fashion Show part 3: Knitwear, Sportswear, Menswear

open access: yes
Knitwear, Sportswear, and Menswear designed by graduating students in FIT's BFA fashion design program.

core  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

DESIGN FOR SUSTAINABLE FASHION: A SUSTAINABILITY DESIGN-ORIENTING TOOL FOR FASHION

open access: yes, 2019
Fashion is recognised as one of the most unsustainable systems, being characterized by both severe environmental impacts and unfair working conditions. In this framework, the article describes the design support tool called Sustainability design-orienting scenario for fashion and its development process.
B. Azzi, C. Vezzoli, G. M. Conti
openaire   +1 more source

2010 FIT Fashion Show part 1: Special Occasion and Menswear

open access: yes
Special Occasion and Menswear designed by graduating students in FIT's BFA fashion design program.

core  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy